WallStreetZenWallStreetZen

NASDAQ: IART
Integra Lifesciences Holdings Corp Stock

$32.80-0.35 (-1.06%)
Updated Apr 12, 2024
IART Price
$32.80
Fair Value Price
$36.61
Market Cap
$2.57B
52 Week Low
$32.50
52 Week High
$59.30
P/E
38.59x
P/B
1.62x
P/S
2.26x
PEG
0.51x
Dividend Yield
N/A
Revenue
$1.54B
Earnings
$67.74M
Gross Margin
57.4%
Operating Margin
8.59%
Profit Margin
4.4%
Debt to Equity
1.38
Operating Cash Flow
$140M
Beta
0.9
Next Earnings
Apr 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

IART Overview

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IART scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IART ($32.80) is undervalued by 10.41% relative to our estimate of its Fair Value price of $36.61 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
IART ($32.80) is not significantly undervalued (10.41%) relative to our estimate of its Fair Value price of $36.61 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IART ($32.80) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IART due diligence checks available for Premium users.

Be the first to know about important IART news, forecast changes, insider trades & much more!

IART News

Valuation

IART fair value

Fair Value of IART stock based on Discounted Cash Flow (DCF)
Price
$32.80
Fair Value
$36.61
Undervalued by
10.41%
IART ($32.80) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IART ($32.80) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IART ($32.80) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IART price to earnings (PE)

For valuing profitable companies with steady earnings
Company
38.59x
Industry
29.43x
Market
42.64x
IART is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IART is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

IART price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.62x
Industry
3.74x
IART is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IART price to earnings growth (PEG)

For valuing profitable companies with growth potential
IART is good value based... subscribe to Premium to read more.
PEG Value Valuation

IART's financial health

Profit margin

Revenue
$397.0M
Net Income
$19.8M
Profit Margin
5%
IART's Earnings (EBIT) of $132.45M... subscribe to Premium to read more.
Interest Coverage Financials
IART's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.8B
Liabilities
$2.2B
Debt to equity
1.38
IART's short-term assets ($1.06B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IART's long-term liabilities ($1.89B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IART's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
IART's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$58.8M
Investing
-$57.2M
Financing
-$6.9M
IART's operating cash flow ($139.96M)... subscribe to Premium to read more.
Debt Coverage Financials

IART vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
IART$2.57B-1.06%38.59x1.62x
PRCT$2.58B-4.89%-22.64x9.21x
NARI$2.36B-1.78%-1,359.33x5.08x
QDEL$2.82B-1.88%-281.13x0.56x
CNMD$2.30B-1.96%35.51x2.75x

Integra Lifesciences Holdings Stock FAQ

What is Integra Lifesciences Holdings's quote symbol?

(NASDAQ: IART) Integra Lifesciences Holdings trades on the NASDAQ under the ticker symbol IART. Integra Lifesciences Holdings stock quotes can also be displayed as NASDAQ: IART.

If you're new to stock investing, here's how to buy Integra Lifesciences Holdings stock.

What is the 52 week high and low for Integra Lifesciences Holdings (NASDAQ: IART)?

(NASDAQ: IART) Integra Lifesciences Holdings's 52-week high was $59.30, and its 52-week low was $32.50. It is currently -44.69% from its 52-week high and 0.92% from its 52-week low.

How much is Integra Lifesciences Holdings stock worth today?

(NASDAQ: IART) Integra Lifesciences Holdings currently has 78,219,780 outstanding shares. With Integra Lifesciences Holdings stock trading at $32.80 per share, the total value of Integra Lifesciences Holdings stock (market capitalization) is $2.57B.

Integra Lifesciences Holdings stock was originally listed at a price of $4.44 in Dec 31, 1997. If you had invested in Integra Lifesciences Holdings stock at $4.44, your return over the last 26 years would have been 638.74%, for an annualized return of 7.99% (not including any dividends or dividend reinvestments).

How much is Integra Lifesciences Holdings's stock price per share?

(NASDAQ: IART) Integra Lifesciences Holdings stock price per share is $32.80 today (as of Apr 12, 2024).

What is Integra Lifesciences Holdings's Market Cap?

(NASDAQ: IART) Integra Lifesciences Holdings's market cap is $2.57B, as of Apr 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Integra Lifesciences Holdings's market cap is calculated by multiplying IART's current stock price of $32.80 by IART's total outstanding shares of 78,219,780.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.